Mn Services Vermogensbeheer B.V. Cuts Stock Position in Danaher Corporation $DHR

Mn Services Vermogensbeheer B.V. lessened its stake in Danaher Corporation (NYSE:DHR) by 6.4% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 240,700 shares of the conglomerate’s stock after selling 16,500 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Danaher were worth $47,548,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MGO One Seven LLC increased its holdings in Danaher by 485.7% in the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after acquiring an additional 20,813 shares in the last quarter. UniSuper Management Pty Ltd increased its holdings in Danaher by 1.6% in the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after acquiring an additional 2,667 shares in the last quarter. Asahi Life Asset Management CO. LTD. purchased a new stake in Danaher in the 1st quarter worth $539,000. Horizon Financial Services LLC grew its holdings in shares of Danaher by 20,400.0% during the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after buying an additional 8,160 shares in the last quarter. Finally, Focus Partners Wealth grew its holdings in shares of Danaher by 10.7% during the first quarter. Focus Partners Wealth now owns 196,682 shares of the conglomerate’s stock worth $40,328,000 after buying an additional 19,086 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 1.1%

Shares of DHR opened at $192.54 on Thursday. The stock has a market capitalization of $137.87 billion, a PE ratio of 40.97, a P/E/G ratio of 2.66 and a beta of 0.75. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company’s 50-day simple moving average is $200.61 and its 200-day simple moving average is $198.55.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio is currently 27.23%.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on DHR shares. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price for the company in a report on Friday, July 11th. Evercore ISI dropped their target price on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a report on Tuesday, July 8th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. UBS Group dropped their target price on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Finally, Wells Fargo & Company dropped their target price on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a report on Wednesday, July 23rd. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $246.35.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.